Caplin Point Laboratories Ltd - 524742 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Caplin Point Laboratories Ltd.

NSE: CAPLIPOINT | BSE: 524742 | ISIN: INE475E01026 | Industry: Pharmaceuticals
| Falling Comet

1806.7000 -77.70 (-4.12%)

NSE Apr 25, 2025 15:31 PM

31.59% Fall from 52W High

Volume: 113.2K

Caplin Point Laboratories Ltd.

23 Apr 2025

1806.70

-4.12%

Company Update

Caplin Point Laboratories Ltd - 524742 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Press Release regarding receipt of USFDA Approval is attached herewith.

More from Caplin Point Laboratories Ltd.

Recommended

Five Interesting Stocks Today - April 25, 2025

The Baseline | 25 Apr 2025

Market closes lower, Maruti Suzuki's Q4 net profit misses Forecaster estimates by 4%

Trendlyne Marketwatch | 25 Apr 2025

Caplin Point Laboratories maintains export momentum, expands ambitions to new markets